Corvus PharmaceuticalsCRVS
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 47 institutions reported holding Corvus Pharmaceuticals Inc. (CRVS) in their 13F filings, unchanged from Q1 2024. 7 opened new positions and 7 sold out. The largest holders were Orbimed Advisors LLC ($12.6M), Samlyn Capital, LLC ($11.1M) and Point72 Asset Management ($10.9M). 4 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Corvus Pharmaceuticals Inc.
- CUSIP
- 221015100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $11.2M |
| Exits | 7 | $698K |
All 13F filers, Q1 2024 → Q2 2024: 10,519,827 shares bought and 827,885 shares sold, net +9,691,942 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 47 holders
| Orbimed Advisors LLC | 0.25% | No change | 6,943,654 | $12.6M |
| Samlyn Capital, LLC | 0.19% | Add +160.7% | 6,123,021 | $11.1M |
| Point72 Asset Management | 0.04% | New | 5,964,510 | $10.9M |
| Adams Street Partners LLC | 2.46% | No change | 3,275,616 | $6.0M |
| Vanguard Group Inc. | 0.00% | Add +10.5% | 1,650,500 | $3.0M |
| Renaissance Technologies | 0.00% | Reduce -11.5% | 563,932 | $1.0M |
| BlackRock Inc. | 0.00% | Add +7.5% | 562,024 | $1.0M |
| Geode Capital Management, LLC | 0.00% | Add +23.8% | 460,140 | $838K |
| Towerview LLC | 0.48% | Add +4.6% | 400,000 | $728K |
| Morgan Stanley | 0.00% | Add +34.9% | 371,403 | $676K |
| Millennium Management | 0.00% | Add +778.8% | 204,598 | $372K |
| Bridgeway Capital Management, LLC | 0.01% | Reduce -43.3% | 127,300 | $232K |
| State Street Corp. | 0.00% | No change | 120,303 | $219K |
| Two Sigma Advisers, LP | 0.00% | Reduce -38.7% | 113,400 | $206K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Reduce -5.4% | 83,222 | $151K |
| Northern Trust Corp. | 0.00% | Add +27.8% | 82,990 | $151K |
| Marshall Wace, LLP | 0.00% | New | 74,559 | $136K |
| Jackson Square Capital, LLC | 0.03% | No change | 63,773 | $116K |
| Citadel Advisors | 0.00% | New | 53,010 | $96K |
| Hikari Power Ltd | 0.01% | No change | 49,959 | $91K |
| Two Sigma Investments, LP | 0.00% | Reduce -53.4% | 47,786 | $87K |
| Susquehanna International Group, LLP | 0.00% | Reduce -75.6% | 25,650 | $47K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 24,364 | $44K |
| Quinn Opportunity Partners LLC | 0.00% | No change | 22,327 | $41K |
| Commerce Bank | 0.00% | No change | 20,000 | $36K |
| American Century Companies Inc. | 0.00% | No change | 18,248 | $33K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 15,668 | $29K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +32.9% | 15,300 | $28K |
| OneDigital Investment Advisors LLC | 0.00% | Reduce -18.9% | 14,550 | $26K |
| UBS Group AG | 0.00% | Add +177.8% | 13,000 | $24K |
| Dimensional Fund Advisors LP | 0.00% | No change | 11,924 | $22K |
| Avity Investment Management Inc. | 0.00% | Add +0.9% | 11,580 | $21K |
| Two Sigma Securities, LLC | 0.00% | New | 11,384 | $21K |
| Whittier Trust Co. of Nevada Inc. | 0.00% | No change | 11,200 | $20K |
| Masso Torrence Wealth Management Inc. | 0.01% | No change | 10,000 | $18K |
| JPMorgan Chase & Co. | 0.00% | Reduce -82.7% | 9,152 | $17K |
| Royal Bank of Canada | 0.00% | New | 7,238 | $13K |
| Rothschild Investment LLC | 0.00% | No change | 7,000 | $13K |
| Northwest Capital Management Inc | 0.00% | No change | 3,397 | $6K |
| Simplex Trading, LLC | 0.00% | Reduce -76.3% | 2,212 | $4K |
| Rhumbline Advisers | 0.00% | No change | 791 | $1K |
| Osaic Holdings, Inc. | 0.00% | Reduce -55.5% | 534 | $971 |
| Bank of America Corp. | 0.00% | New | 392 | $713 |
| FMR LLC | 0.00% | Add +211.8% | 53 | $96 |
| IFP Advisors, Inc | 0.00% | No change | 24 | $44 |
| Parallel Advisors, LLC | 0.00% | No change | 20 | $36 |
| Barclays PLC | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is CRVS's weight in each manager's 13F, not the share of Corvus Pharmaceuticals Inc. the manager owns.